About 100 Mg Glivec Flim Tablets
Experience the premier standard in anticancer therapy with 100 Mg Glivec Flim Tablets, brought to you by Novartis Pharma AG. Featuring Imatinib Mesylate (100 mg) as the prime ingredient, these film-coated tablets are engineered for controlled release and optimal efficacy, earning global recognition and US FDA approval. Now available at the best price for bulk orders, Glivec is an essential medication for Chronic Myeloid Leukemia (CML) and Gastrointestinal Stromal Tumors (GIST). Lowest price offers are accessible for distributors, exporters, suppliers, and traders across India. Use under medical supervision only.
First-String Cancer Therapy with Distinct Competitive Advantages
100 Mg Glivec Flim Tablets deliver valorous performance in the management of CML and GIST. As a selective tyrosine kinase inhibitor, this premier medication offers enhanced efficacy with polymeric film coating for controlled oral release. Ideal for adult and pediatric patients (per physician's advice), Glivec's US FDA approval and inclusion in the WHO Essential Medicines list affirm its global reputation and clinical reliability.
Sample Availability, Market Presence, and Packaging Drop-off Insights
Samples of 100 Mg Glivec Flim Tablets are available for valuation and quality assessment to registered distributors and healthcare professionals. The main domestic market covers the entirety of India, ensuring efficient drop-off and distribution channels. Each pack is securely sealed in original packaging to preserve product integrity, helping you reduce operational expenditure while maintaining the highest pharmaceutical standards throughout the supply process.
FAQ's of 100 Mg Glivec Flim Tablets:
Q: How is 100 Mg Glivec Flim Tablet administered and what patient group is it recommended for?
A: 100 Mg Glivec Flim Tablet is administered orally and is intended for both adults and children, following a physician's prescription. It is formulated to treat Chronic Myeloid Leukemia (CML) and Gastrointestinal Stromal Tumors (GIST).
Q: What competitive advantages does Glivec offer compared to other anticancer therapies?
A: Glivec stands out with its premier, first-string performance as a selective tyrosine kinase inhibitor, controlled-release polymeric coating, US FDA approval, and inclusion on the WHO Essential Medicines list, ensuring reliable and effective treatment.
Q: When should Glivec be stored and handled with care?
A: Glivec should always be stored below 30C, in its original packaging, protected from moisture, and kept away from children. Do not freeze the tablets. Check the packaging for specific expiry information.
Q: Where can distributors access the lowest price for Glivec and is sample drop-off available?
A: Distributors, exporters, and suppliers across India are eligible for best price and lowest price offers. Samples are available for evaluation, subject to medical and regulatory requirements.
Q: What is the process for purchasing Glivec Flim Tablets as a supplier or exporter?
A: Suppliers and exporters can request quotations, negotiate bulk orders for optimal expenditure, and arrange secure packaging and drop-off through authorized distribution channels.
Q: What are the key features of Glivec's formulation and how does it support patient therapy?
A: Glivec utilizes Imatinib Mesylate (100 mg) in a round, orange to dark yellow, film-coated tablet for controlled, reliable oral dosing, aiding in effective and consistent anticancer therapy under medical supervision.